The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
about
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesDiagnosis and differential diagnosis of hepatic graft versus host disease (GVHD)A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationPersistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation.Epstein-barr virus related lymphoproliferations after stem cell transplantation.Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.Effects of spleen status on early outcomes after hematopoietic cell transplantation.Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT.Strategy of pre-emptive management of Epstein-Barr virus post-transplant lymphoproliferative disorder after stem cell transplantation: results of European transplant centers survey.
P2860
Q26745838-FD256C52-3413-4ED4-9656-C7F688625B32Q26749007-BB72ED0B-DE3B-4E0F-9503-906DA9CFAF55Q33573529-BC0F2C95-91D7-4AAE-AE2A-06B4AA177B32Q34180261-443540AA-D7C3-4110-B43F-7C19110D68F2Q34549457-48D3958D-57CD-4605-80B2-BFBFCB1EF04BQ34622755-81A82670-2BAE-4B2C-AED2-9BF9186A5420Q36712192-36889DA3-DB13-4EDF-8E15-0201085E6EA0Q37426542-F2014D12-F870-4AD2-BD49-9E93B745C130Q37552052-00557DA0-D742-427B-870C-8AACE5022C5DQ39978862-43213548-CB20-47DF-9AEC-03B65872768FQ43121166-D6F0F21F-4A0E-4457-82B7-58D6F4A1E55D
P2860
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
The role of HLA mismatch, sple ...... tic stem cell transplantation.
@en
The role of HLA mismatch, sple ...... tic stem cell transplantation.
@nl
type
label
The role of HLA mismatch, sple ...... tic stem cell transplantation.
@en
The role of HLA mismatch, sple ...... tic stem cell transplantation.
@nl
prefLabel
The role of HLA mismatch, sple ...... tic stem cell transplantation.
@en
The role of HLA mismatch, sple ...... tic stem cell transplantation.
@nl
P2093
P1433
P1476
The role of HLA mismatch, sple ...... etic stem cell transplantation
@en
P2093
Brigitta Omazic
Christina Lergin
Katarina Le Blanc
Lisbeth Barkholt
Mats Remberger
Olle Ringdén
Victor Levitsky
P304
P577
2006-08-01T00:00:00Z